Shinkai M, Ebisawa M, Fukushima Y, Takeuchi S, et al. One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study. J Asthma 2022 Jun 16:1-9. doi: 10.1080/02770903.2022.2082309.
PMID: 35707873